73 results
F-1
EX-10.1
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
EXHIBIT 10.1
BioLine Therapeutics Ltd.
May 1, 2003
Dr. Morris Laster
11 Reuven Shari Street
Jerusalem 97246
Dear Morris,
Re: Engagement Offer … to or by which you are bound; and (ii) do not require the consent of any person or entity. Further, with respect to any past engagement you may have
20FR12B
EX-4.1
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
EXHIBIT 4.1
BioLine Therapeutics Ltd.
May 1, 2003
Dr. Morris Laster
11 Reuven Shari Street
Jerusalem 97246
Dear Morris,
Re: Engagement Offer … to or by which you are bound; and (ii) do not require the consent of any person or entity. Further, with respect to any past engagement you may have
F-1
EX-10.3
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
EXHIBIT 10.3
October 13, 2004
Dr. Kinneret Savitsky
44 Metudela Street
Tel Aviv
Re: Engagement Offer
Further to our discussions, this is to set … forth in writing our agreements regarding your engagement as the General Manager of a wholly owned subsidiary company which may be established by us
20FR12B
EX-4.3
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
EXHIBIT 4.3
October 13, 2004
Dr. Kinneret Savitsky
44 Metudela Street
Tel Aviv
Re: Engagement Offer
Further to our discussions, this is to set … forth in writing our agreements regarding your engagement as the General Manager of a wholly owned subsidiary company which may be established by us
F-1
EX-10.2
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
EXHIBIT 10.2
January 8, 2004
Dr. Moshe Phillip
51 Shimon Ben Tsvi Street
Givataim, Israel
Re: Engagement Offer
We would like to congratulate … . Further, with respect to any past engagement you may have had with third parties and with respect to any engagement you may have with any third party
20FR12B
EX-4.2
rriknf7 0m
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.21
lzjj9kws79c d9
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.22
s9q4l2183j5wva
24 Sep 10
Registration statement (foreign)
12:00am
F-1
EX-10.21
nxytzl462xmc
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.20
rjflr6m39lvmkdz3
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.5
stl6x59hi7
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.5
qa13f3
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
68v5 grxisyab
20 Mar 13
BioLineRx Announces Results from Interim Analysis of
12:00am